Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Cel-Sci, Johns Hopkins collaboration centers on novel strategy for treating autoimmune disease

Nov. 16, 1999

Two Amgen antiarthritics are better than one: synergistic effects of cytokine inhibitors

Nov. 16, 1999

Anakinra plus methotrexate effective, safe in patients not responding to MTX alone

Nov. 16, 1999

News from ACR/ARHP: Amgen's TNF-targeting therapy is effective in RA

Nov. 16, 1999

Centaur presents new antiarthritic drug candidate, the free radical spin trap NRT-115

Nov. 16, 1999

Hydroxamate-based metalloproteinase inhibitors in the P&G pipeline

Nov. 16, 1999

Isis presents findings for antisense treatment of RA at ACR

Nov. 16, 1999

COX-2 inhibitor MK-663 provides significant pain relief in osteoarthritic patients

Nov. 16, 1999

Inhibitors of TNF-alpha production/release in early development at Sumitomo

Nov. 12, 1999

Synvisc under study for osteoarthritis of the hip

Nov. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...